Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tobias Loddenkemper, M.D.

Co-Author

This page shows the publications co-authored by Tobias Loddenkemper and Catherine Chu.
Connection Strength

0.452
  1. Comparative Effectiveness of Initial Treatment for Infantile Spasms in a Contemporary US Cohort. Neurology. 2021 Jul 15.
    View in: PubMed
    Score: 0.062
  2. Immediate outcomes in early life epilepsy: A contemporary account. Epilepsy Behav. 2019 08; 97:44-50.
    View in: PubMed
    Score: 0.054
  3. Neuroimaging of Early Life Epilepsy. Pediatrics. 2018 09; 142(3).
    View in: PubMed
    Score: 0.051
  4. Comparative Effectiveness of Levetiracetam vs Phenobarbital for Infantile Epilepsy. JAMA Pediatr. 2018 04 01; 172(4):352-360.
    View in: PubMed
    Score: 0.050
  5. Why West? Comparisons of clinical, genetic and molecular features of infants with and without spasms. PLoS One. 2018; 13(3):e0193599.
    View in: PubMed
    Score: 0.049
  6. The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium. Epilepsia. 2017 12; 58(12):2098-2103.
    View in: PubMed
    Score: 0.048
  7. Early-Life Epilepsies and the Emerging Role of Genetic Testing. JAMA Pediatr. 2017 09 01; 171(9):863-871.
    View in: PubMed
    Score: 0.048
  8. Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus. Pediatr Neurol. 2017 Oct; 75:73-79.
    View in: PubMed
    Score: 0.047
  9. Response to treatment in a prospective national infantile spasms cohort. Ann Neurol. 2016 Mar; 79(3):475-84.
    View in: PubMed
    Score: 0.043
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.